Humans Clamor For Weight Loss Drugs, But The Next Users Could Be... Pets?
Humans Clamor For Weight Loss Drugs, But The Next Users Could Be... Pets?
Americans love their pets: could the success of Novo Nordisk A/S (NYSE:NVO) drugs Ozempic and Wegovy and Eli Lilly And Co's (NYSE:LLY) Zepbound be a model for similar weight loss drugs in the pet market?
美國人熱愛他們的寵物：諾和諾德醫藥股份有限公司（紐交所：NVO）的奧澤匹克和威高維（Wegovy）以及禮來（紐交所：LLY）的Zepbound，能否成爲寵物減肥藥類似的模型？
What Happened: A recent Bloomberg newsletter outlined several recent developments in the push to introduce GLP-1 drugs to overweight four-legged friends.
發生了什麼：彭博新聞簡報概述了推出GLP-1藥物用於過重的四腿朋友的幾項最新進展。
Okava Pharmaceuticals and Vivani Medical are reportedly developing weight loss drugs for cats. Okava, a biotech startup, released a study in May that found success in administering the drugs to felines. Better Choice Company Inc (NYSEAMERICAN: BTTR) bought Aimia Pet Healthco in February in a push to develop GLP-1 drugs.
據報道，Okava製藥公司和Vivani醫學正在開發用於貓的減肥藥物。生物技術初創公司Okava於5月發佈了一份研究，發現將藥物施用於貓咪是成功的。Better Choice Company Inc（紐交所美國股市：BTTR）於2月份收購了Aimia Pet Healthco，推出了GLP-1藥物。
Veterinary experts interviewed by Bloomberg expressed skepticism that weight loss drugs are a practical solution for most pets. Other factors, such as a better diet and plenty of exercise, were cited as more sensible choices to help pets battle obesity.
接受彭博社採訪的獸醫專家們對於減肥藥物是否是大多數寵物的實際解決方案表示懷疑。其他因素，例如更好的飲食和充足的鍛鍊，被引用爲幫助寵物應對肥胖症的更明智選擇。
Why it Matters: The pet industry is projected to see substantial increases in size in the coming years. The introduction of weight loss drugs by Novo Nordisk and Eli Lilly has driven both stocks to all-time highs and could be replicated by pet companies.
爲什麼這很重要：寵物行業預計在未來幾年將大幅增長。諾和諾德醫藥股份有限公司和禮來的減肥藥物推出推動着兩家公司的股票創下歷史新高，並可能被寵物公司複製。
According to a survey by the Association for Pet Obesity Prevention, approximately 60% of dogs and cats in the U.S. are overweight or obese.
根據美國寵物肥胖預防協會的一項調查，美國約60%的狗和貓超重或肥胖。
The pet industry has seen an outsized amount of activity in mergers and acquisitions and consolidation, in particular by private equity companies such as Blackstone Inc (NYSE:BX) and KKR & Co Inc (NYSE:KKR).
寵物行業在兼併收購和整合方面看到了大量的活動，特別是由黑石集團（紐交所：BX）和KKR＆Co Inc（紐交所：KKR）等私人股權公司進行的活動。
Also Read: Chewy Stock 'Attractive' After Q4 Earnings, But Wall Street Flags 'Weak' Pet Care Sector
另請參閱：Chewy股票在Q4業績後“有吸引力”，但華爾街標記出“弱化”的寵物護理板塊
Image: Pixabay
圖片：Pixabay
譯文內容由第三人軟體翻譯。